GYRE Net Income Growth
Gyre Therapeutics Inc · Net Income Growth
GYRE Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-501.16%period ending
GYRE TTM Net Income YoY % (107.23% → -501.16%)
Year-over-year change
High-resolution chart · PNG
GYRE net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -501.1571% | |
| -184.5539% | |
| -57.1121% | |
| 107.6636% | |
| 105.0262% | |
| 108.2731% | |
| 113.004% | |
| -2,033.6769% | |
| -3,059.6825% | |
| -286.2483% | |
| -406.9308% | |
| -65.7941% | |
| 67.8805% | |
| 158.7999% | |
| 134.4332% | |
| 115.5226% | |
| 89.0422% | |
| -7.2428% | |
| -56.3503% | |
| -69.8159% | |
| -62.3496% | |
| -69.0321% | |
| -1.9246% | |
| 2.7898% | |
| -0.4705% | |
| -10.1082% | |
| -83.5934% | |
| -109.8674% | |
| -105.4356% | |
| -78.4821% | |
| -39.3952% | |
| -27.6767% | |
| -24.4605% | |
| -28.4301% | |
| -27.2336% | |
| -6.7227% | |
| 0.3762% | |
| 3.4071% | |
| 20.3254% | |
| 11.7542% | |
| 9.5743% | |
| 25.7097% | |
| 34.8037% | |
| 49.7909% | |
| 58.3507% | |
| 54.5546% | |
| 30.1509% | |
| 15.9483% | |
| -11.8069% | |
| -209.6346% | |
| -567.405% | |
| -5,174.2765% | |
| -1,996.1101% | |
| 8.1349% | |
| 17.9505% | |
| -5.0676% | |
| -119.7897% | |
| -212.9771% | |
| -178.2549% | |
| 93.3453% | |
| 173.4823% | |
| 159.758% | |
| 127.6603% | |
| 27.5766% | |
| 47.1082% | |
| -13.7406% | |
| -53.5521% | |
| 33.9094% | |
| 0.7033% | |
| 15.4986% | |
| 8.5915% | |
| -672.3673% | |
| -2,398.8946% | |
| -1,243.563% | |
| -1,439.0173% | |
| 83.0131% | |
| 95.2602% | |
| 109.4851% | |
| 107.2315% |